Eton Pharmaceuticals Reports Q3 2026 Earnings: Revenue Soars to $57.9 Million, GAAP EPS at $1. ...
Record product sales and a one-time tax benefit drive GAAP EPS of $1.06, while raised full-year guidance signals continued momentum Related Stocks: ETON ,